United States · Bill · HR
H.R. 728 (117th)
Pandemic Emergency Manufacturing Act of 2021
Introduced
2 February 2021
Last action
3 February 2021 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Schakowsky, Janice D. [D-IL-9], Sheila Jackson Lee
Subjects
Healthcare
Source updated
5 December 2025
Summary
Pandemic Emergency Manufacturing Act of 2021 This bill establishes within the Department of Health and Human Services (HHS) an Emergency Office of Manufacturing for Public Health to manufacture and distribute medical products to address COVID-19 (i.e., coronavirus disease 2019) or medical products that are on shortage or vulnerable to shortage. The office must (1) obtain the rights to manufacture the applicable medicines, ingredients, diagnostic tests, medical devices, personal protective equipment, and supplies; (2) manufacture or contract to manufacture such items; and (3) construct, or enter into construction contracts for, facilities to manufacture certain medicines, such as vaccines. HHS may issue involuntary licenses allowing the office to make, use, sell, import, or export an invention related to an applicable drug, biological product, or device and to use clinical trial data and confidential information. Such a license must provide the rights holder with reasonable compensation. The office must (1) provide such COVID-19 products at no cost to federal, state, local, and other health programs and certain domestic health care providers and suppliers; (2) offer COVID-19 products at cost to other commercial and international entities; and (3) offer other medical products to entities at a fair price, based on cost and other considerations. The office shall prioritize the manufacture of certain COVID-19 products and meet manufacturing timelines specified in the bill.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
2 February 2021
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
2 February 2021
Introduced
Introduced in House
Source: IntroReferral
2 February 2021
Introduced
Introduced in House
Source: IntroReferral
3 February 2021
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 2 February 2021 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 2 February 2021
Introduced in House (PDF)
Introduced in House · EN · 2 February 2021
Introduced in House
summary · EN · 2 February 2021
Sponsors
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Sponsor
- Sheila Jackson Lee · D · Cosponsor
- · hsif00 · Standing
Related records
- related to ← Pandemic Emergency Manufacturing Act of 2021
- related to ← COVID–19 Emergency Manufacturing Act of 2020
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/728
- Open data entity: https://api.congress.gov/v3/bill/117/hr/728
- us · 117-hr-728 · source updated 5 December 2025